Cargando…
Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results
Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-solu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747167/ https://www.ncbi.nlm.nih.gov/pubmed/23977207 http://dx.doi.org/10.1371/journal.pone.0072057 |
_version_ | 1782280879008120832 |
---|---|
author | Herrmann, Inge K. Castellon, Maricela Schwartz, David E. Hasler, Melanie Urner, Martin Hu, Guochang Minshall, Richard D. Beck-Schimmer, Beatrice |
author_facet | Herrmann, Inge K. Castellon, Maricela Schwartz, David E. Hasler, Melanie Urner, Martin Hu, Guochang Minshall, Richard D. Beck-Schimmer, Beatrice |
author_sort | Herrmann, Inge K. |
collection | PubMed |
description | Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-soluble primary sevoflurane metabolite – has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, p = 0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis. |
format | Online Article Text |
id | pubmed-3747167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37471672013-08-23 Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results Herrmann, Inge K. Castellon, Maricela Schwartz, David E. Hasler, Melanie Urner, Martin Hu, Guochang Minshall, Richard D. Beck-Schimmer, Beatrice PLoS One Research Article Volatile anesthetics are known to have immunomodulatory effects in conditions of organ injury. A recent study in an experimental sepsis model has shown remarkably improved survival when mice were exposed to volatile anesthetics. In the present study, we show that hexafluoroisopropanol – a water-soluble primary sevoflurane metabolite – has beneficial effects on the overall survival in a murine model of cecal ligation and puncture. Seven-day survival as well as tissue damage markers including transaminases and high mobility group box protein-1 were assessed as measures of end organ damage. In animals undergoing cecal ligation and puncture procedure hexafluoroisopropanol conditioning - but not late postconditioning 24 hours after sepsis induction - significantly increased survival rate (17% vs. 77%, p = 0.037) and attenuated secretion of organ damage markers. This study shows survival benefits by administration of the metabolite of a volatile anesthetic. If successfully translated, hexafluoroisopropanol might offer interesting therapeutic opportunities in the future treatment of abdominal sepsis. Public Library of Science 2013-08-19 /pmc/articles/PMC3747167/ /pubmed/23977207 http://dx.doi.org/10.1371/journal.pone.0072057 Text en © 2013 Herrmann et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Herrmann, Inge K. Castellon, Maricela Schwartz, David E. Hasler, Melanie Urner, Martin Hu, Guochang Minshall, Richard D. Beck-Schimmer, Beatrice Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title | Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title_full | Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title_fullStr | Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title_full_unstemmed | Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title_short | Intravenous Application of a Primary Sevoflurane Metabolite Improves Outcome in Murine Septic Peritonitis: First Results |
title_sort | intravenous application of a primary sevoflurane metabolite improves outcome in murine septic peritonitis: first results |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747167/ https://www.ncbi.nlm.nih.gov/pubmed/23977207 http://dx.doi.org/10.1371/journal.pone.0072057 |
work_keys_str_mv | AT herrmanningek intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT castellonmaricela intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT schwartzdavide intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT haslermelanie intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT urnermartin intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT huguochang intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT minshallrichardd intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults AT beckschimmerbeatrice intravenousapplicationofaprimarysevofluranemetaboliteimprovesoutcomeinmurinesepticperitonitisfirstresults |